Daxor Corporation (DXR) ニュース

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN...

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form N-2 - Registration statement for closed-end investment companies

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide

Daxor's ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE...

Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer

The Hematocrit Feature Will Be Integrated Into A Future Generation Blood Volume Analyzer (BVA) Oak Ridge, TN...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities